These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Thrombolysis in coronary occlusion--the full circle. Bauer GE Aust N Z J Med; 1989 Apr; 19(2):85-7. PubMed ID: 2504138 [No Abstract] [Full Text] [Related]
43. Intravenous bolus application of streptokinase and of anisoylated plasminogen streptokinase activator complex in acute myocardial infarction. Clinical and haemostaseological findings. Hellstern P; Doenecke P; Köhler M; Schwerdt H; Ozbek C; Miyashita C; Bette L; Wenzel E Drugs; 1987; 33 Suppl 3():183-5. PubMed ID: 3315589 [No Abstract] [Full Text] [Related]
44. Treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex in a district hospital. Efficacy data. Chamberlain DA Drugs; 1987; 33 Suppl 3():221-2. PubMed ID: 3315596 [No Abstract] [Full Text] [Related]
52. Treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex in a district hospital. Tolerance data. Chamberlain DA Drugs; 1987; 33 Suppl 3():286. PubMed ID: 3315609 [No Abstract] [Full Text] [Related]
53. Thrombolytic therapy in acute myocardial infarction: an overview (continuing education credit). Henderson E J Emerg Nurs; 1989; 15(2( Pt 2)):145-51. PubMed ID: 2495375 [TBL] [Abstract][Full Text] [Related]
54. The use of BRL26921 (APSAC) as fibrinolytic therapy in acute myocardial infarction. Hillis WS; Hornung RS Eur Heart J; 1985 Nov; 6(11):909-12. PubMed ID: 3908105 [No Abstract] [Full Text] [Related]
55. Biochemical and pharmacologic comparison of thrombolytic agents. Stringer KA Pharmacotherapy; 1996; 16(5 Pt 2):119S-126S. PubMed ID: 8888099 [TBL] [Abstract][Full Text] [Related]
56. [At home thrombolysis. 100 cases]. Hervé C; Gaillard M; Castaigne A; Jan F; Huguenard P Presse Med; 1988 Dec; 17(43):2308. PubMed ID: 2974965 [No Abstract] [Full Text] [Related]
57. Eligibility for thrombolytic therapy in acute myocardial infarction. Jagger JD; Murray RG; Davies MK; Littler WA; Flint EJ Lancet; 1987 Jan; 1(8523):34-5. PubMed ID: 2879104 [TBL] [Abstract][Full Text] [Related]
58. Systemic effects of BRL 26921 during thrombolytic treatment of acute myocardial infarction. Hoffmann JJ; Van Rey FJ; Bonnier JJ Thromb Res; 1985 Mar; 37(5):567-72. PubMed ID: 3920779 [TBL] [Abstract][Full Text] [Related]
59. Management of myocardial infarction in the community: a new RCGP study. Kay C Br J Gen Pract; 1991 Mar; 41(344):89-90. PubMed ID: 1903264 [No Abstract] [Full Text] [Related]
60. Should we intervene following thrombolytic therapy? The SWIFT study in progress. UK APSAC Advisory Committee. Drugs; 1987; 33 Suppl 3():229-30. PubMed ID: 3315599 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]